Transcription Factor-Based Drug Design in Anticancer Drug Development

Molecular Medicine - United States
doi 10.1007/bf03401717
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Anticancer Drug Development: The Way Forward

Oncologist
Cancer ResearchMedicineOncology
1996English

Anticancer Drug Discovery — From Serendipity to Rational Design

2013English

Is Anticancer Drug Development Heading in the Right Direction?

Cancer Research
Cancer ResearchOncology
2009English

Anticancer Drug Targets: Growth Factors and Growth Factor Signaling

Journal of Clinical Investigation
Medicine
2000English

Structure Based Drug Design

Acta Crystallographica Section A Foundations of Crystallography
1993English

CDK4 as a Phytochemical Based Anticancer Drug Target

2019English

EGFr, FGFr and PDGFr: Emerging Targets for Anticancer Drug Design

Journal of Cancer Research Updates
2016English

Clinical Anticancer Drug Development: Targeting the Cyclin-Dependent Kinases

British Journal of Cancer
Cancer ResearchOncology
2004English

Early Stage Release Control of an Anticancer Drug by Drug-Polymer Miscibility in a Hydrophobic Fiber-Based Drug Delivery System

RSC Advances
ChemistryChemical Engineering
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy